Who owns CNS PHARMACEUTICALS INC?
- CUSIP Number: 18978h409
Tip: Access positions for across all investors
Analyze quarterly positions in Cns Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cns Pharmaceuticals stock
Who bought or sold CNS PHARMACEUTICALS INC this quarter?
There are no current stakeholders of Cns Pharmaceuticals.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Cns Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| UBS Group | Jun 2025 | 32k | $27k |
| Virtu Financial | Jun 2025 | 23k | $19k |
| Geode Capital Management | Jun 2025 | 18k | $15k |
| Two Sigma Securities | Jun 2025 | 16k | $13k |
| Hrt Financial | Jun 2025 | 11k | $8.0k |
| Tower Research Capital | Jun 2025 | 6.7k | $5.6k |